Aspirin and myocardial infarction
NHS Centre for Reviews and Dissemination
Record ID 31999008341
English
Authors' objectives:
To summarise the evidence relating to the use of aspirin following myocardial infarction.
Authors' recommendations:
Aspirin as emergency therapy:
Aspirin is an effective therapy in patients with acute myocardial infarction.
Patients with suspected acute myocardial infarction should receive 150mg aspirin daily.
There are very few contraindications for the immediate use of aspirin.
Intravenous thrombolytic therapy:
Intravenous thrombolytic therapy is also effective in suitable patients.
The benefit of thrombolysis reduces as the time from onset of symptoms increases.
In patients with acute myocardial infarction, combining thrombolysis and aspirin is more effective than using either therapy alone.
Local guidelines on ensuring rapid access to treatment should be developed and implemented.
Long-term use of aspirin:
Aspirin protects patients with a history of cardiovascular disease from fatal and non fatal myocardial infarction and stroke.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.york.ac.uk/inst/crd/em.htm
Year Published:
1995
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Aspirin
- Infusions, Intravenous
- Thrombolytic Therapy
- Myocardial Infarction
Contact
Organisation Name:
University of York
Contact Address:
University of York, York, Y01 5DD, United Kingdom. Tel: +44 1904 321040, Fax: +44 1904 321041,
Contact Name:
crd@york.ac.uk
Contact Email:
crd@york.ac.uk
Copyright:
Centre for Reviews and Dissemination
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.